Clinical Review: New Rt Inhibitors - Islatravir - Jean-Michel Molina, Md, Phd,

Clinical Review: New RT inhibitors – Islatravir - Jean-Michel Molina, MD, PhD,

Academic Medical Education

Clinical Review: New RT Inhibitors – Islatravir - Francois Venter

Academic Medical Education

Recent Clinical Trials: What Does the Data Tell Us? | Jean-Michel Molina, MD, PhD

Academic Medical Education

Update on the Long-Acting Antivirals for Treatment - Jean-Michel Molina, MD, PhD

Academic Medical Education

Clinical Review: New RT inhibitors – Doravirine - Chloe Orkin, MBChB, FRCP, MD

Academic Medical Education

Gaining Insights into Islatravir and Doravirine

How to Choose Between Oral and IM PrEP for Each Individual - Jean-Michel Molina, MD, PhD

Academic Medical Education

HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina

Academic Medical Education

IAS 2021: Professor Jean-Michel Molina talks about injectable treatment for multidrug-resistant HIV

Clinical Review: New RT Inhibitors – Doravirine - Laura Waters

Academic Medical Education

Brett Tindall Memorial Lecture 2017: Professor Jean-michel Molina – On Demand PrEP: only for Europe

Kirby Institute

Clinical update: Highly treatment experienced patients | Michael Kozal, MD

Academic Medical Education

MSD HIV Pipeline: Islatravir as the Foundation of Novel Prevention ... | Kathleen E. Squires, MD

Academic Medical Education

Record Infections & HIV Studies │ GOLD Weekly News Roundup

EMJ

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future | Session 2

Academic Medical Education

Session 3: Resistance to Long-Acting Antivirals | Full Livestream

Academic Medical Education

Current and upcoming treatment strategies for upper tract urothelial cancer

CROI 2022 Review

ECCMID Keynote speaker Jean-Michel Molina on the future of HIV prevention